Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Shutterstock Inc.

Start price
Target price
Perf. (%)
€70.60
06.03.23
€84.46
06.03.24
-35.07%
07.03.24

buy
Ulta Salon

Start price
Target price
Perf. (%)
€490.40
06.03.23
€539.58
06.03.24
1.96%
07.03.24

buy
Clear Channel Outdoor Holdings Inc.

Start price
Target price
Perf. (%)
€1.46
06.03.23
€2.35
06.03.24
9.59%
07.03.24

buy
DineEquity Inc.

Start price
Target price
Perf. (%)
€69.00
06.03.23
€77.89
06.03.24
-32.17%
07.03.24

buy
Monster Beverage Corp.

Start price
Target price
Perf. (%)
€48.20
06.03.23
€56.30
06.03.24
10.33%
07.03.24

buy
Bridgebio Pharma Inc.

Start price
Target price
Perf. (%)
€15.95
06.03.23
€25.00
06.03.24
72.37%
07.03.24

Could be worthwhile Investment >10% per year
Good culture
Capable Management
No uniques
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.29
06.03.23
-
06.03.24
-13.18%
17.03.23

Risky Investment
buy
Deutsche Lufthansa AG

Start price
Target price
Perf. (%)
€10.87
06.03.23
€14.00
06.03.24
-28.08%
15.11.23

Could be worthwhile Investment >10% per year
Fair valuation
buy
E.ON SE

Start price
Target price
Perf. (%)
€10.34
06.03.23
€13.00
06.03.24
15.92%
11.05.23

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.44
06.03.23
-
06.03.24
-57.46%
17.03.23

Could be worthwhile Investment >10% per year
buy
Blue Apron Holdings Inc.

Start price
Target price
Perf. (%)
€10.26
06.03.23
€24.00
06.03.24
-17.78%
21.03.23

Could be very worthwhile Investment >20% year
buy
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€1.47
06.03.23
-
06.03.24
-95.09%
07.03.24

Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
buy
Okta Inc.

Start price
Target price
Perf. (%)
€81.26
06.03.23
€111.00
06.03.24
-16.34%
16.04.23

Innovative
Medium risks for its business
High valuation
Low dividend yield expected
buy
Okyo Pharma Ltd.

Start price
Target price
Perf. (%)
€2.12
06.03.23
€2.00
06.03.24
-33.49%
07.03.24

Small challenges to pay loans and raise capital
Risky balance sheet
Little known brand
buy
iBio Inc.

Start price
Target price
Perf. (%)
€1.55
06.03.23
€3.00
06.03.24
-38.59%
16.04.23

Some uniques
Significant cyclical dependencies
Little known brand
Higher risks for its business
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€85.00
06.03.23
€66.00
06.03.24
91.76%
07.03.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Innovative
buy
Deutsche Bank AG

Start price
Target price
Perf. (%)
€11.72
05.03.23
€13.00
05.03.24
1.33%
11.12.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
BMW AG ADR

Start price
Target price
Perf. (%)
€33.20
05.03.23
€36.00
05.03.24
1.81%
12.04.23

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Undervalued
Top Rating
buy
BMW AG ST

Start price
Target price
Perf. (%)
€101.44
05.03.23
€110.00
05.03.24
2.50%
17.04.23

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
BMW AG VZO

Start price
Target price
Perf. (%)
€93.45
05.03.23
€100.00
05.03.24
1.12%
31.03.23

Leading role in innovation
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
Volkswagen AG ST

Start price
Target price
Perf. (%)
€180.55
05.03.23
€150.00
05.11.24
-26.45%
16.03.24

EBIT growth > 30% per year expected
High dividend yield expected
positive Cash Flow expected
Good rating
buy
Sixt SE VZO

Start price
Target price
Perf. (%)
€78.00
05.03.23
€80.00
05.03.24
-1.92%
24.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
ADLER Group S.A.

Start price
Target price
Perf. (%)
€1.08
05.03.23
-
05.03.24
-9.81%
17.03.23

Risky Investment
Novavax Inc.

Start price
Target price
Perf. (%)
€7.14
05.03.23
-
05.03.24
-22.15%
18.03.23

Probably not worthwhile Investment
Very low/no dividend yield expected
BioNTech SE ADR

Start price
Target price
Perf. (%)
€123.90
05.03.23
-
05.03.24
-8.23%
29.03.23

Very low/no dividend yield expected
Probably not worthwhile Investment